Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition

Molecular and Cellular Proteomics

Volumn 11, Issue 5, 2012, Pages 148-159

  Udeshi, Namrata D ^a   Mani, D R ^a   Eisenhaure, Thomas ^a,b   Mertins, Philipp ^a   Jaffe, Jacob D ^a   Clauser, Karl R ^a   Hacohen, Nir ^a,b   Carr, Steven A ^a  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IODOACETAMIDE; PR 619; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

CELL LYSATE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL LINE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; STOICHIOMETRY; UBIQUITINATION;

ALKYLATING AGENTS; AMINOPYRIDINES; ENDOPEPTIDASES; HUMANS; IODOACETAMIDE; ISOTOPE LABELING; JURKAT CELLS; LEUPEPTINS; PEPTIDE FRAGMENTS; POLYUBIQUITIN; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; PROTEOME; THIOCYANATES; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84861151032     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.016857     Document Type: Conference Paper

References (32)

1. Myung, J., Kim, K. B., and Crews, C. M. (2001) The ubiquitin-proteasome pathway and proteasome inhibitors. Med. Res. Rev. 21, 245-273 (Pubitemid 32565494)
2. Dikic, I., Wakatsuki, S., and Walters, K. J. (2009) Ubiquitin-binding domains [mdash] from structures to functions. Nat. Rev. Mol. Cell Biol. 10, 659-671
3. Cohen, P., and Tcherpakov, M. (2010) Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases? Cell 143, 686-693
4. Sacco, J. J., Coulson, J. M., Clague, M. J., and Urbé, S. (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life 62, 140-157
5. Komander, D., Clague, M. J., and Urbé, S. (2009) Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563
6. Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J., and Brownell, J. E. (2011) Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat. Rev. Drug Discov. 10, 29-46
7. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., and Mann, M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (Pubitemid 44647421)
8. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., and Gygi, S. P. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189
9. Danielsen, J. M. R., Sylvestersen, K. B., Bekker-Jensen, S., Szklarczyk, D., Poulsen, J. W., Horn, H., Jensen, L. J., Mailand, N., and Nielsen, M. L. (2010) Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol. Cell. Proteomics 10, M110.003590
10. Xu, G., Paige, J. S., and Jaffrey, S. R. (2010) Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 28, 868-873
11. Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M., and Choudhary, C. (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics. 10, M111.013284
12. Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J., Harper, J. W., and Gygi, S. P. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell. 44, 325-340
13. Altun, M., Kramer, Holger, H. B., Willems, L. I., McDermott, J. L., Leach, C. A., Goldenberg, S. J., Kumar, K. G., Konietzny, R., Fischer, R., Kogan, E., Mackeen, M. M., McGouran, J., Khoronenkova, S. V., Parsons, J. L., Dianov, G. L., Nicholson, B., and Kessler, B. M. (2011) Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem. Biol. 18, 1401-1412
14. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 1, 376-386
15. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906 (Pubitemid 47308128)
16. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
17. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment. J. Proteome Res. 10, 1794-1805
18. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Meth. 4, 207-214 (Pubitemid 46358868)
19. Seyfried, N. T., Xu, P., Duong, D. M., Cheng, D., Hanfelt, J., and Peng, J. (2008) Systematic approach for validating the ubiquitinated proteome. Anal. Chem. 80, 4161-4169 (Pubitemid 351812770)
20. Smyth, G. K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3
21. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Statistical Soc. B 57, 289-300
22. Huang, D. W., Sherman, B. T., and Lempicki, R. A. (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
23. Huang, da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
24. GENE-E. http://www.broadinstitute.org/cancer/software/GENE-E/:
25. Nielsen, M. L., Vermeulen, M., Bonaldi, T., Cox, J., Moroder, L., and Mann, M. (2008) Iodoacetamide-induced artifact mimics ubiquitination in mass spectrometry. Nat. Methods 5, 459-460 (Pubitemid 351761746)
26. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771 (Pubitemid 24294452)
27. Tanaka, K., and Tsurumi, C. (1997) The 26S proteasome: subunits and functions. Mol. Biol. Reports 24, 3-11 (Pubitemid 27269419)
28. Dantuma, N. P., Groothuis, T. A. M., Salomons, F. A., and Neefjes, J. (2006) A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. The J. Cell Biol. 173, 19-26
29. Xu, Q., Farah, M., Webster, J. M., and Wojcikiewicz, R. J. H. (2004) Bortezomib rapidly suppresses ubiquitin thiolesterification to ubiquitin-conjugating enzymes and inhibits ubiquitination of histones and type I inositol 1,4,5-trisphosphate receptor. Mol. Cancer Therap. 3, 1263-1269 (Pubitemid 39440171)
30. Murata, S., Yashiroda, H., and Tanaka, K. (2009) Molecular mechanisms of proteasome assembly. Nat. Rev. Mol. Cell Biol. 10, 104-115
31. Ren, Y., Zhao, J., and Feng, J. (2003) Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation. J. Neurosci. 23, 3316-3324 (Pubitemid 36531973)
32. Dammer, E. B., Na, C. H., Xu, P., Seyfried, N. T., Duong, D. M., Cheng, D., Gearing, M., Rees, H., Lah, J. J., Levey, A. I., Rush, J., and Peng, J. (2011) Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 286, 10457-10465